Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P694: Genetic predisposition and thiopurine-induced pancreatitis in inflammatory bowel disease patients

ECCO '19 Copenhagen

Year: 2019
Authors:

G. Burnet*1, N. de Suray2, B. De Vroey3, P. Hoang4, J-C. Coche5, M. Denis1, J-L. Gala6, O. Dewit1

1Cliniques Universitaires St-Luc, Gastroenterology, Brussels, Belgium, 2Grand Hôpital de Charleroi, Gastroenterology, Charleroi, Belgium, 3Centres Hospitaliers Jolimont, Gastroenterology, Haine-Saint-Paul, Belgium, 4Clinique Sainte-Elisabeth, Gastroenterology, Namur, Belgium, 5Clinique St Pierre, Gastroenterology, Ottignies, Belgium, 6Université Catholique de Louvain, Centre de Technologies Moléculaires Appliquées, Institut de Recherche Expérimentale et Clinique, Brussels, Belgium

P695: Feasibility and safety of strictureplasties performed by laparoscopic approach for complicated Crohn’s disease: A prospective observational cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

G. M. Sampietro1, F. Colombo*1, A. Frontali2, C. Baldi1, L. Conti1, D. Dilillo3, P. Fiorina4, G. Maconi5, S. Ardizzone5, F. Corsi6, G. Zuccotti3, D. Foschi1

1Luigi Sacco University Hospital, General Surgery, Milano, Italy, 2Hôpiteau de Paris (AP-HP), Beaujon Hospital, University Denis Diderot, Department of Colorectal Surgery, Pôle des Maladies de l'Appareil Digestif (PMAD), Paris, France, 3Luigi Sacco University Hospital, Division of Pediatrics, Milano, Italy, 4Luigi Sacco University Hospital, Division of Endocrinology, Milano, Italy, 5Luigi Sacco University Hospital, Gastroenterology, Milano, Italy, 6ICS Maugeri, General Surgery Department, Pavia, Italy

P696: Long-term prognosis and predictive factors for surgical treatment of intestinal lesions in patients with Behcet’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

T. Chohno*1, K. Watanabe1, T. Minagawa1, R. Kuwahara1, Y. Horio1, H. Sasaki1, T. Bando1, M. Uchino1, H. Ikeuchi1

1Hyogo College of Medicine, Inflammatory Bowel Disease, Nishinomiya, Hyogo, Japan

P697: Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s)

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Vieujean*1, A. Moens2, K. Rothfuss3, E. Savarino4, S. Vavricka5, C. Reenaers1, M. Ferrante2, J-F. Rahier6, ECCO CONFER Investigators1

1University Hospital of Liège, Department of Gastroenterology, Liège, Belgium, 2University Hospitals Leuven, Department of Gastroenterology and Hepatology, Leuven, Belgium, 3Robert-Bosch-Hospital, Department of Gastroenterology and Hepatology, Stuttgart, Germany, 4University of Padua, Department of Gastroenterology, Padua, Italy, 5University Hospital, Department of Gastroenterology and Hepatology, Zurich, Switzerland, 6CHU UCL Namur, Department of Gastroenterology and Hepatology, Yvoir, Belgium

P698: Persistence, clinical effectiveness and safety of vedolizumab in the post-marketing real clinical practice in Italy: a double-centre, 2-year experience in Crohn’s disease and ulcerative colitis patients

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Sartini*1, R. Solimando2, A. Curatolo1, M. C. Verga1, A. Bertani1, M. Di Girolamo3, A. Merighi2, E. Villa1

1Struttura Complessa di Gastroenterologia Azienda Ospedaliero - Universitaria di Modena, Policlinico, Modena, Italy, 2Gastroenterologia Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale Sant'Anna, Ferrara, Italy, 3Azienda USL Modena, Modena, Italy

P699: Faecal microbiota transplantation as treatment for recurrent clostridium difficile infections: a single-centre experience

ECCO '19 Copenhagen

Year: 2019
Authors:

C. Caenepeel*1, A. Schroë1, K. Van den Broeck2, M. Ferrante1,2, S. Vermeire1,2

1KU Leuven, TARGID, Leuven, Belgium, 2University hospitals Leuven, Gastroenterology and Hepatology, Leuven, Belgium

P700: The efficacy of colesevelam to treat bile acid malabsorption in Crohn's disease: data from TOPPIC trial

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Devarakonda*1, I. Arnott2, J. Satsangi3

1The University of Edinburgh, Gastroenterology, Edinburgh, UK, 2Western General Hospital, Gastroenterology, Edinburgh, UK, 3University of Edinburgh, Edinburgh, UK

P701: The comparative safety of different intravenous iron preparations in inflammatory bowel disease: a systematic review and network meta-analysis

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Aksan*1,2, H. Işık2, K. Farrag1,3, A. Dignass4, J. Stein1,3

1Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, 2Hacettepe University, Ankara, Turkey, 3DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, 4Agaplesion Markuskrankenhaus, Frankfurt/Main, Germany

P702: Off-label drug use in patients with inflammatory bowel disease: a national survey among tertiary care centres

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Simsek*1, F. Hoentjen2, B. Oldenburg3, C. Y. Ponsioen4, J. van der Woude5, A. E. van der Meulen6, M. Pierik7, G. Dijkstra8, N. K. de Boer1

1Amsterdam UMC, VU Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 2Radboud University Medical Center, Gastroenterology and Hepatology, Nijmegen, The Netherlands, 3University Medical Center Utrecht, Gastroenterology and Hepatology, Utrecht, The Netherlands, 4Amsterdam UMC, Academical Medical Center, Gastroenterology and Hepatology, Amsterdam, The Netherlands, 5Erasmus University Medical Center, Gastroenterology and Hepatology, Rotterdam, The Netherlands, 6Leiden University Medical Center, Gastroenterology and Hepatology, Leiden, The Netherlands, 7Maastricht University Medical Center, Gastroenterology and Hepatology, Maastricht, The Netherlands, 8University Medical Center Groningen and University of Groningen, Gastroenterology and Hepatology, Groningen, The Netherlands

P703: The real-world long-term effectiveness of vedolizumab in inflammatory bowel diseases: a single-centre observational study

ECCO '19 Copenhagen

Year: 2019
Authors:

F. S. Macaluso*1, A. Croce1, R. Orlando1, M. Ventimiglia1, C. Sapienza1, F. Gambino1, E. Orlando1, M. Grova1, G. Rizzuto1, S. Renna1, M. Cottone1, A. Orlando1

1IBD Unit, "Villa Sofia-Cervello" Hospital, Palermo, Italy

P704: Association between trough levels of vedolizumab and therapy outcome in a cohort of patients with inflammatory bowel disease

ECCO '19 Copenhagen

Year: 2019
Authors:

J. O'Connell1, P. McDonagh1, K. Hazel2, J. Fiona3, C. Dunne1,4, R. Farrell2, G. Harewood3, K. Hartery1,4, O. Kelly2, F. MacCarthy4,5, S. McKiernan1,4, F. Murray3, C. O'Morain6, O. Aoibhlinn3, D. Kevans1,4

1St James's Hospital, Department of Gastroenterology, Dublin, Ireland, 2Connolly Hospital Blanchardstown, Gastroenterology, Dublin, Ireland, 3Beaumont Hospital, Gastroenterology, Dublin, Ireland, 4INITIative, Investigator Network Inflammatory bowel disease Therapy in Ireland, Dublin, Ireland, 5St James's Hospital, Gastroenterology, Dublin, Ireland, 6Beacon Hospital, Gastroenterology, Dublin, Ireland

P705: Incidence and risk factors of micronutrient deficiency in the patients with inflammatory bowel disease in Korea: folate, vitamin B12, 25-OH-vitamin D, ferritin

ECCO '19 Copenhagen

Year: 2019
Authors:

Y. E. Park*1, S. J. Park2, Y. Park2, J. H. Cheon2, T. I. Kim2, W. H. Kim2

1Haeundae Paik Hospital, Division of Gastroenterology, Department of Internal Medicine, Busan, South Korea, 2Yonsei University College of Medicine, Seoul, Korea, Division of Gastroenterology, Department of Internal Medicine, Seoul, South Korea

P706: Patient knowledge towards biological treatment in inflammatory bowel diseases: a cross-sectional survey

ECCO '19 Copenhagen

Year: 2019
Authors:

M. Wiśniewska-Jarosińska*1, M. Włodarczyk2, A. Gąsiorowska1, J. Fichna3, A. Sobolewska-Włodarczyk1

1Medical University of Lodz, Department of Gastroenterology, Lodz, Poland, 2Medical University of Lodz, Department of General and Colorectal Surgery, Lodz, Poland, 3Medical University of Lodz, Department of Biochemistry, Lodz, Poland

P707: 38 Weeks treatment of UC patients with different daily doses of mesalazine

ECCO '19 Copenhagen

Year: 2019
Authors:

R. Laoun*1, R. Hofmann2

1Tillotts Pharma AG, Medical Affairs, Rheinfelden, Switzerland, 2Tillotts Pharma, Medicines Management, Rheinfelden, Switzerland

P708: Prospective study to predict psychological morbidity in young people with inflammatory bowel disease using novel risk assessment tool

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Hoogkamer*1, A. Brooks1, G. Rowse2, P. Norman2, A. Lobo1

1University of Sheffield, Academic Department of Gastroenterology, Sheffield, UK, 2University of Sheffield, Academic Department of Psychology, Sheffield, UK

P709: Early measurement of serum cytokines as predictor of clinical and endoscopic outcome to vedolizumab in patients with ulcerative colitis

ECCO '19 Copenhagen

Year: 2019
Authors:

L. Bertani*1, L. Antonioli2, L. Baglietto2, G. Tapete1, E. Albano1, M. G. Mumolo3, L. Ceccarelli3, S. Maltinti1, M. Fornai2, S. Marchi1, C. Blandizzi2, F. Costa3

1University of Pisa, Department of new technologies and translational sciences in medicine and surgery, Pisa, Italy, 2University of Pisa, Department of clinical and experimental medicine, Pisa, Italy, 3Pisa University Hospital, Department of General Surgery and Gastroenterology, Pisa, Italy

P710: The use of first-line biologics in patients with Crohn’s disease in Norway from 2011 to 2016

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Anisdahl*1,2, S. Lirhus3, A. Medhus1, L. Buer1,2, H. O. Melberg3, B. Moum1,2, M. Lie Høivik1

1Oslo University Hospital, Department of Gastroenterology, Oslo, Norway, 2University of Oslo, Institute of Clinical Medicine, Oslo, Norway, 3University of Oslo, Institute of Health and Society, Oslo, Norway

P711: The real-life experience of vedolizumab therapy in the OBSERV-IBD cohort: a 3-year prospective observational multi-centre cohort study

ECCO '19 Copenhagen

Year: 2019
Authors:

A. Amiot*1, M. Serrero2, L. Peyrin-Biroulet3, J. Filippi4, B. Pariente5, X. Roblin6, A. Buisson7, C. Stefanescu8, C. Trang-Poisson9, R. Altwegg10, P. Marteau11, T. Vaysse12, A. Bourrier13, S. Nancey14, D. Laharie15, M. Allez16, G. Savoye17, J. Moreau18, L. Vuitton19, S. Viennot20, A. Aubourg21, A-L. Pelletier22, G. Bouguen23, V. Abitbol24, M. Fumery25, C. Gagniere1, Y. Bouhnik8

1Henri Mondor Hospital, Gastroenterology, Creteil, France, 2Hopital Nord, Gastroenterology, Marseille, France, 3CHU Nancy, Gastroenterology, Nancy, France, 4CHU Nice, Gastroenterology, Nice, France, 5CHU Lille, Gastroenterology, Lille, France, 6CHU Saint-Etienne, Gastroenterology, Saint-Etienne, France, 7CHU Clermont-Ferrand, Gastroenterology, Clermont-Ferrand, France, 8CHU Beaujon, Gastroenterology, Clichy, France, 9CHU Nantes, Gastroenterology, Nantes, France, 10CHU Montpellier, Gastroenterology, Montpellier, France, 11CHU Lariboisiere, Gastroenterology, Paris, France, 12CHU Bicetre, Gastroenterology, Kremlin-Bicetre, France, 13CHU Saint-Antoine, Gastroenterology, Paris, France, 14CHU Lyon, Gastroenterology, Lyon, France, 15CHU Bordeaux, Gastroenterology, Bordeaux, France, 16CHU Saint-Louis, Gastroenterology, Paris, France, 17CHU Rouen, Gastroenterology, Rouen, France, 18CHU Toulouse, Gastroenterology, Toulouse, France, 19CHU Besancon, Gastroenterology, Besancon, France, 20CHU Caen, Gastroenterology, Caen, France, 21CHU Tours, Gastroenterology, Tours, France, 22CHU Bichat, Gastroenterology, Paris, France, 23CHU rennes, Gastroenterology, Rennes, France, 24CHU COchin, Gastroenterology, Paris, France, 25CHU Amiens, Gastroenterology, Amiens, France

P712: Tofacitinib efficacy in patients with moderate to severe ulcerative colitis: Subgroup analyses of OCTAVE Induction 1 and 2 and OCTAVE Sustain by 5-aminosalicylates use

ECCO '19 Copenhagen

Year: 2019
Authors:

S. Hanauer1, D. T. Rubin2, P. Gionchetti3, C. Su4, D. A. Woodworth4, D. Quirk4, L. Salese4, W. Wang4, A. Marren4, N. Lawendy4, R. Panaccione*5

1Northwestern University, Feinberg School of Medicine, Chicago, IL, USA, 2University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, IL, USA, 3University of Bologna, Department of Medical and Surgical Sciences (DIMEC), Bologna, Italy, 4Pfizer Inc., Collegeville, PA, USA, 5University of Calgary, Calgary, AB, Canada

P713: Long-term efficacy of endoscopic balloon dilatation using single-balloon enteroscopy in patients with Crohn’s disease

ECCO '19 Copenhagen

Year: 2019
Authors:

K. Takahashi*1, S. Bamba2, Y. Morita1, A. Nishida1, M. Sasaki2, T. Tsujikawa3, A. Andoh1

1Shiga University of Medical Science, Department of gastroenterology, Otsu, Japan, 2Shiga University of Medical Science, Division of Clinical Nutrition, Otsu, Japan, 3Shiga University of Medical Science, Department of Comprehensive Internal Medicine, Otsu, Japan